MARJAN
1.11.2021 12:50:12 CET | Business Wire | Press release
The Organising Committee for the Ras Al Khaimah New Year’s Eve celebration is planning yet another Guinness World Records-worthy spectacular pyrotechnic fireworks performance, which will feature pyrodrones, lights, colours and shapes to welcome 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211101005544/en/
Covering a 4.7km stretch along the waterfront between Al-Marjan Island and Al-Hamra Village, the 12-minute spectacle, open to the public and set to clinch two Guinness World Records, will be accompanied by a crescendo of modern and dynamic music to reflect a new spirit of optimism.
#RAKNYE2022 will also welcome the public to enjoy a host of family oriented activities and events that will keep visitors enthralled until the countdown starts for the mesmersising display. These activities will spread across Al -Marjan Island and along the waterfront between Al- Marjan Island and Al -Hamra Village, which includes entertainment, children’s play areas, family gathering areas, and F&B outlets, details of which will be announced soon. To keep up-to-date, please log on to raknye.com .
The high-level Organising Committee reiterated its focus on taking all precautionary measures to ensure the safety of the public through co-ordination with the National Authority for Emergency, Crisis & Disaster Management and the Ministry of Health & Prevention. Safety protocols are to be followed by all attendees. The Committee, which consists of members from Marjan, Ras Al Khaimah Police, Ras Al Khaimah Government Media Office, Ras Al Khaimah Tourism Development Authority, Ras Al Khaimah Chamber of Commerce, Public Works, Ras Al Khaimah Municipality, Al Hamra and others, is leading the preparations for the event.
Earlier this year, Ras Al Khaimah welcomed 2021 with a dazzling 10-minute fireworks show that underlined the UAE’s message of hope, peace and achievements. Ras Al Khaimah made history with the New Year’s Eve Gala of 2020, which won the GUINNESS WORLD RECORDS™ titles for the ‘Most Unmanned Aerial Vehicles for Launching Fireworks Simultaneously’ and the ‘Longest Fireworks Waterfall.’ The Emirate also secured two GUINNESS WORLD RECORDS™ for the ‘Longest chain of fireworks’ and the ‘Longest straight line of fireworks’ with the 2019 New Year’s Eve Fireworks.
To access the video, please visit: #RAKNYE2022
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20211101005544/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom